acetyl coenzyme a has been researched along with Liver Steatosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, P; Shang, L; Wang, Y; Yao, H; Zeng, J; Zhang, X | 1 |
| Cholico, GN; Fader, KA; Fling, RR; Nault, R; Orlowska, K; Sink, WJ; Zacharewski, NA; Zacharewski, T | 1 |
| Chen, Y; Hu, W; Lu, Y; Wang, M; Wen, X; Yang, J | 1 |
| Chen, X; Chen, Y; Dean, JM; He, A; Lodhi, IJ; Lu, D; Razani, B; Tan, M; Zhang, X | 1 |
| Arany, Z; Gosis, B; Jang, C; Lee, G; Rabinowitz, JD; Shen, Y; Wada, S; Yang, S; Zeng, X; Zhang, Z | 1 |
| Chen, X; Tang, K; Wang, F; Xu, X; Zeng, Y | 1 |
| Cai, L; Estill, SJ; Huang, Z; McKnight, SL; Plec, AA; Repa, JJ; Tu, BP; Zhang, M | 1 |
| Cai, Y; Chakraborty, J; Chakraborty, T; Chatterjee, R; Chen, Y; Garcia-Milian, R; Golla, S; Gonzalez, FJ; Krausz, KW; Manna, SK; Thompson, DC; Vasiliou, V | 1 |
| Koo, SH | 1 |
| Barminko, J; Berthiaume, F; Maguire, TJ; Nativ, NI; Schloss, R; So, A; Yarmush, G; Yarmush, ML | 1 |
| Gao, X; Jiang, L; Li, S; Li, W; Liu, Y; Rui, L; Wang, J; Wang, Q; You, J; Yu, Y; Zeng, R | 1 |
| Carvalho, RA; Jones, JG; Nunes, PM; Palmeira, CM; Rolo, AP | 1 |
| Cristea, I; Gaskell, SJ; Guest, PC; Knowles, MR; Lawrence, J; Meneses-Lorente, G; Mortishire-Smith, R; Muniappa, N; Salim, K; Skynner, HA; Watt, A | 1 |
| Choi, CS; Cline, GW; Coleman, RA; Hammond, LE; Liu, ZX; Morino, K; Neschen, S; Pongratz, RL; Romanelli, AJ; Shulman, GI; Zhang, D; Zhang, XM | 1 |
| Hirata, H; Liu, W; Masutani, H; Nakamura, H; Oka, S; Shinkai, Y; Yamada, S; Yodoi, J; Yoshida, T | 1 |
1 review(s) available for acetyl coenzyme a and Liver Steatosis
| Article | Year |
|---|---|
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.
Topics: Acetyl Coenzyme A; Fatty Acids; Fatty Liver; Humans; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Triglycerides | 2013 |
14 other study(ies) available for acetyl coenzyme a and Liver Steatosis
| Article | Year |
|---|---|
Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice.
Topics: Acetyl Coenzyme A; Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Fatty Acids; Fatty Liver; Insulin Resistance; Liver; Malonyl Coenzyme A; Mice; Mice, Obese; Obesity; Oxidation-Reduction | 2023 |
Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver.
Topics: 3-Hydroxybutyric Acid; Acetyl Coenzyme A; Animals; Fatty Liver; Liver; Mice; Polychlorinated Dibenzodioxins | 2023 |
Inhibition of ACSS2 attenuates alcoholic liver steatosis via epigenetically regulating de novo lipogenesis.
Topics: Acetate-CoA Ligase; Acetyl Coenzyme A; Animals; Epigenesis, Genetic; Ethanol; Fatty Liver; Fatty Liver, Alcoholic; Histones; Lipogenesis; Liver; Liver Diseases, Alcoholic; Mice | 2023 |
Acetyl-CoA Derived from Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation.
Topics: Acetyl Coenzyme A; Acetylation; Acyl-CoA Oxidase; Animals; Autophagy; Autophagy-Related Protein 5; Diet, High-Fat; Fasting; Fatty Acids; Fatty Liver; Female; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Mitochondria; Oxidation-Reduction; Peroxisomes; Regulatory-Associated Protein of mTOR | 2020 |
The small intestine shields the liver from fructose-induced steatosis.
Topics: Acetyl Coenzyme A; Administration, Oral; Animals; Diet; Fatty Acids, Nonesterified; Fatty Liver; Fructokinases; Fructose; Gastrointestinal Microbiome; Humans; Hyperlipidemias; Intestine, Small; Lipogenesis; Metabolic Syndrome; Mice; Mice, Knockout; Mice, Transgenic | 2020 |
Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice.
Topics: Acetyl Coenzyme A; Animals; Atherosclerosis; Carnitine O-Palmitoyltransferase; Cholesterol 7-alpha-Hydroxylase; Diet, High-Fat; Fatty Acid Synthases; Fatty Liver; Hyperlipidemias; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipids; Male; Mice, Knockout; PPAR alpha; Receptors, LDL; Tumor Necrosis Factor-alpha; Weight Gain | 2018 |
ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism.
Topics: Acetate-CoA Ligase; Acetyl Coenzyme A; Adipose Tissue; Animals; Fatty Liver; Gene Expression Regulation; Lipid Metabolism; Liver; Mice; Mice, Knockout | 2018 |
Glutathione deficiency-elicited reprogramming of hepatic metabolism protects against alcohol-induced steatosis.
Topics: Acetyl Coenzyme A; Alcohol Drinking; AMP-Activated Protein Kinases; Animals; Ethanol; Fatty Acids; Fatty Liver; Glucuronic Acid; Glutamate-Cysteine Ligase; Glutamates; Glutathione; Homeostasis; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Oxidative Stress; Pentose Phosphate Pathway; Protective Agents; Transcription, Genetic | 2019 |
Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol.
Topics: Acetyl Coenzyme A; Adenosine Triphosphate; Animals; Carnitine; Cytosol; Fatty Liver; Hepatocytes; Hypoxia; Ketone Bodies; L-Lactate Dehydrogenase; Liver Transplantation; Male; Mitochondria; Oxygen; Perfusion; Rats; Rats, Zucker; Reactive Oxygen Species; Reperfusion Injury; Transplantation Conditioning; Triglycerides | 2014 |
Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Topics: Acetyl Coenzyme A; Animals; ATP Citrate (pro-S)-Lyase; Fatty Acids, Nonesterified; Fatty Liver; Glucose; Homeostasis; Hyperglycemia; Insulin Resistance; Lipid Metabolism; Lipogenesis; Liver; Male; Malonyl Coenzyme A; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Leptin; RNA Interference | 2009 |
Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study.
Topics: Acetyl Coenzyme A; Animals; Body Weight; Carbon Isotopes; Fatty Liver; Glucose; In Vitro Techniques; Liver; Magnetic Resonance Spectroscopy; Male; Organ Size; Oxidation-Reduction; Perfusion; Rats; Rats, Wistar; Tissue Extracts; Ursodeoxycholic Acid | 2011 |
A proteomic investigation of drug-induced steatosis in rat liver.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Acetyl Coenzyme A; Animals; Aryldialkylphosphatase; Biomarkers; Electrophoresis, Gel, Two-Dimensional; Fatty Liver; Female; Glucose; Mass Spectrometry; Oxidoreductases Acting on Sulfur Group Donors; Peroxidases; Peroxiredoxins; Phenylalanine Hydroxylase; Proteomics; Pyruvate Dehydrogenase Complex; Rats; Serum Albumin; Transaminases; Triglycerides | 2004 |
Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice.
Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Dietary Fats; Diglycerides; Fasting; Fatty Liver; Glucose Tolerance Test; Glycerol-3-Phosphate O-Acyltransferase; Insulin Resistance; Liver; Lysophospholipids; Male; Malonyl Coenzyme A; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Multienzyme Complexes; Phenotype; Protein Serine-Threonine Kinases; Triglycerides | 2005 |
Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome.
Topics: Acetyl Coenzyme A; Animals; Blood Coagulation; Carrier Proteins; Disease Models, Animal; Fasting; Fatty Acids; Fatty Liver; Food Deprivation; Gene Deletion; Glucose; Hemorrhage; Mice; Reye Syndrome; Thioredoxins | 2006 |